4-( N -Alkyl- and -Acyl-amino)-1,2,4-triazole-3-thione Analogs as Metallo-β-Lactamase Inhibitors: Impact of 4-Linker on Potency and Spectrum of Inhibition

To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinan...

Full description

Saved in:
Bibliographic Details
Published inBiomolecules (Basel, Switzerland) Vol. 10; no. 8; p. 1094
Main Authors Gavara, Laurent, Verdirosa, Federica, Legru, Alice, Mercuri, Paola Sandra, Nauton, Lionel, Sevaille, Laurent, Feller, Georges, Berthomieu, Dorothée, Sannio, Filomena, Marcoccia, Francesca, Tanfoni, Silvia, De Luca, Filomena, Gresh, Nohad, Galleni, Moreno, Docquier, Jean-Denis, Hernandez, Jean-François
Format Journal Article Web Resource
LanguageEnglish
Published Switzerland MDPI AG 23.07.2020
MDPI
Multidisciplinary Digital Publishing Institute (MDPI)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinants to β-lactams, and especially carbapenems, in Gram-negative bacteria. These molecules are stable analogs of 4-amino-1,2,4-triazole-derived Schiff bases, where the hydrazone-like bond has been reduced (hydrazine series) or the 4-amino group has been acylated (hydrazide series); the synthesis and physicochemical properties thereof are described. The inhibitory potency was determined on the most clinically relevant acquired MBLs (IMP-, VIM-, and NDM-types subclass B1 MBLs). When compared with the previously reported hydrazone series, hydrazine but not hydrazide analogs showed similarly potent inhibitory activity on VIM-type enzymes, especially VIM-2 and VIM-4, with values in the micromolar to submicromolar range. One of these showed broad-spectrum inhibition as it also significantly inhibited VIM-1 and NDM-1. Restoration of β-lactam activity in microbiological assays was observed for one selected compound. Finally, the binding to the VIM-2 active site was evaluated by isothermal titration calorimetry and a modeling study explored the effect of the linker structure on the mode of binding with this MBL.
AbstractList To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinants to β-lactams, and especially carbapenems, in Gram-negative bacteria. These molecules are stable analogs of 4-amino-1,2,4-triazole-derived Schiff bases, where the hydrazone-like bond has been reduced (hydrazine series) or the 4-amino group has been acylated (hydrazide series); the synthesis and physicochemical properties thereof are described. The inhibitory potency was determined on the most clinically relevant acquired MBLs (IMP-, VIM-, and NDM-types subclass B1 MBLs). When compared with the previously reported hydrazone series, hydrazine but not hydrazide analogs showed similarly potent inhibitory activity on VIM-type enzymes, especially VIM-2 and VIM-4, with Ki values in the micromolar to submicromolar range. One of these showed broad-spectrum inhibition as it also significantly inhibited VIM-1 and NDM-1. Restoration of β-lactam activity in microbiological assays was observed for one selected compound. Finally, the binding to the VIM-2 active site was evaluated by isothermal titration calorimetry and a modeling study explored the effect of the linker structure on the mode of binding with this MBL.
To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinants to β-lactams, and especially carbapenems, in Gram-negative bacteria. These molecules are stable analogs of 4-amino-1,2,4-triazole-derived Schiff bases, where the hydrazone-like bond has been reduced (hydrazine series) or the 4-amino group has been acylated (hydrazide series); the synthesis and physicochemical properties thereof are described. The inhibitory potency was determined on the most clinically relevant acquired MBLs (IMP-, VIM-, and NDM-types subclass B1 MBLs). When compared with the previously reported hydrazone series, hydrazine but not hydrazide analogs showed similarly potent inhibitory activity on VIM-type enzymes, especially VIM-2 and VIM-4, with values in the micromolar to submicromolar range. One of these showed broad-spectrum inhibition as it also significantly inhibited VIM-1 and NDM-1. Restoration of β-lactam activity in microbiological assays was observed for one selected compound. Finally, the binding to the VIM-2 active site was evaluated by isothermal titration calorimetry and a modeling study explored the effect of the linker structure on the mode of binding with this MBL.
To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinants to β-lactams, and especially carbapenems, in Gram-negative bacteria. These molecules are stable analogs of 4-amino-1,2,4-triazole-derived Schiff bases, where the hydrazone-like bond has been reduced (hydrazine series) or the 4-amino group has been acylated (hydrazide series); the synthesis and physicochemical properties thereof are described. The inhibitory potency was determined on the most clinically relevant acquired MBLs (IMP-, VIM-, and NDM-types subclass B1 MBLs). When compared with the previously reported hydrazone series, hydrazine but not hydrazide analogs showed similarly potent inhibitory activity on VIM-type enzymes, especially VIM-2 and VIM-4, with K i values in the micromolar to submicromolar range. One of these showed broad-spectrum inhibition as it also significantly inhibited VIM-1 and NDM-1. Restoration of β-lactam activity in microbiological assays was observed for one selected compound. Finally, the binding to the VIM-2 active site was evaluated by isothermal titration calorimetry and a modeling study explored the effect of the linker structure on the mode of binding with this MBL.
To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report on a new series of 1,2,4-triazole-3-thione compounds as inhibitors of metallo-β-lactamases (MBLs), which represent major resistance determinants to β-lactams, and especially carbapenems, in Gram-negative bacteria. These molecules are stable analogs of 4-amino-1,2,4-triazole-derived Schiff bases, where the hydrazone-like bond has been reduced (hydrazine series) or the 4-amino group has been acylated (hydrazide series); the synthesis and physicochemical properties thereof are described. The inhibitory potency was determined on the most clinically relevant acquired MBLs (IMP-, VIM-, and NDM-types subclass B1 MBLs). When compared with the previously reported hydrazone series, hydrazine but not hydrazide analogs showed similarly potent inhibitory activity on VIM-type enzymes, especially VIM-2 and VIM-4, with K i values in the micromolar to submicromolar range. One of these showed broad-spectrum inhibition as it also significantly inhibited VIM-1 and NDM-1. Restoration of β-lactam activity in microbiological assays was observed for one selected compound. Finally, the binding to the VIM-2 active site was evaluated by isothermal titration calorimetry and a modeling study explored the effect of the linker structure on the mode of binding with this MBL.
Author Legru, Alice
Feller, Georges
Gavara, Laurent
Verdirosa, Federica
Sannio, Filomena
Tanfoni, Silvia
Sevaille, Laurent
Mercuri, Paola Sandra
Docquier, Jean-Denis
Galleni, Moreno
Nauton, Lionel
Hernandez, Jean-François
Marcoccia, Francesca
Gresh, Nohad
Berthomieu, Dorothée
De Luca, Filomena
AuthorAffiliation 4 Institut de Chimie de Clermont-Ferrand, Université Clermont-Auvergne, CNRS, SIGMA Clermont, 63000 Clermont-Ferrand, France; lionel.nauton@uca.fr
1 Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France; alice.legru@umontpellier.fr (A.L.); laurent.sevaille@curie.fr (L.S.)
2 Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy; federica.verdirosa@student.unisi.it (F.V.); filomena.sannio@unisi.it (F.S.); francesca.marcoccia@unisi.it (F.M.); tanfoni.silvia@gmail.com (S.T.); deluca19@unisi.it (F.D.L.)
6 Institut Charles Gerhardt, UMR5253, CNRS, Université de Montpellier, ENSCM, Cedex 5, 34296 Montpellier, France; dorothee.berthomieu@enscm.fr
3 Laboratoire des Macromolécules Biologiques, Centre d’Ingénierie des Protéines-InBioS, Université de Liège, Institute of Chemistry B6 a, Sart-Tilman, 4000 Liège, Belgium; pmercuri@uliege.be (P.S.M.); mgalleni@uliege.be (M.G.)
5 Laboratoire de Bioc
AuthorAffiliation_xml – name: 6 Institut Charles Gerhardt, UMR5253, CNRS, Université de Montpellier, ENSCM, Cedex 5, 34296 Montpellier, France; dorothee.berthomieu@enscm.fr
– name: 3 Laboratoire des Macromolécules Biologiques, Centre d’Ingénierie des Protéines-InBioS, Université de Liège, Institute of Chemistry B6 a, Sart-Tilman, 4000 Liège, Belgium; pmercuri@uliege.be (P.S.M.); mgalleni@uliege.be (M.G.)
– name: 1 Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France; alice.legru@umontpellier.fr (A.L.); laurent.sevaille@curie.fr (L.S.)
– name: 2 Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy; federica.verdirosa@student.unisi.it (F.V.); filomena.sannio@unisi.it (F.S.); francesca.marcoccia@unisi.it (F.M.); tanfoni.silvia@gmail.com (S.T.); deluca19@unisi.it (F.D.L.)
– name: 4 Institut de Chimie de Clermont-Ferrand, Université Clermont-Auvergne, CNRS, SIGMA Clermont, 63000 Clermont-Ferrand, France; lionel.nauton@uca.fr
– name: 5 Laboratoire de Biochimie, Centre d’Ingénierie des Protéines-InBioS, Université de Liège, B6, Sart-Tilman, 4000 Liège, Belgium; gfeller@uliege.be
– name: 7 Laboratoire de Chimie Théorique, UMR7616, Sorbonne Université, CNRS, 75252 Paris, France; gresh@lct.jussieu.fr
Author_xml – sequence: 1
  givenname: Laurent
  surname: Gavara
  fullname: Gavara, Laurent
  organization: Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France
– sequence: 2
  givenname: Federica
  surname: Verdirosa
  fullname: Verdirosa, Federica
  organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy
– sequence: 3
  givenname: Alice
  surname: Legru
  fullname: Legru, Alice
  organization: Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France
– sequence: 4
  givenname: Paola Sandra
  surname: Mercuri
  fullname: Mercuri, Paola Sandra
  organization: Laboratoire des Macromolécules Biologiques, Centre d'Ingénierie des Protéines-InBioS, Université de Liège, Institute of Chemistry B6 a, Sart-Tilman, 4000 Liège, Belgium
– sequence: 5
  givenname: Lionel
  orcidid: 0000-0003-0668-4063
  surname: Nauton
  fullname: Nauton, Lionel
  organization: Institut de Chimie de Clermont-Ferrand, Université Clermont-Auvergne, CNRS, SIGMA Clermont, 63000 Clermont-Ferrand, France
– sequence: 6
  givenname: Laurent
  orcidid: 0000-0002-2347-2495
  surname: Sevaille
  fullname: Sevaille, Laurent
  organization: Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France
– sequence: 7
  givenname: Georges
  orcidid: 0000-0001-8660-0944
  surname: Feller
  fullname: Feller, Georges
  organization: Laboratoire de Biochimie, Centre d'Ingénierie des Protéines-InBioS, Université de Liège, B6, Sart-Tilman, 4000 Liège, Belgium
– sequence: 8
  givenname: Dorothée
  surname: Berthomieu
  fullname: Berthomieu, Dorothée
  organization: Institut Charles Gerhardt, UMR5253, CNRS, Université de Montpellier, ENSCM, Cedex 5, 34296 Montpellier, France
– sequence: 9
  givenname: Filomena
  orcidid: 0000-0003-3001-8159
  surname: Sannio
  fullname: Sannio, Filomena
  organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy
– sequence: 10
  givenname: Francesca
  surname: Marcoccia
  fullname: Marcoccia, Francesca
  organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy
– sequence: 11
  givenname: Silvia
  surname: Tanfoni
  fullname: Tanfoni, Silvia
  organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy
– sequence: 12
  givenname: Filomena
  surname: De Luca
  fullname: De Luca, Filomena
  organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy
– sequence: 13
  givenname: Nohad
  surname: Gresh
  fullname: Gresh, Nohad
  organization: Laboratoire de Chimie Théorique, UMR7616, Sorbonne Université, CNRS, 75252 Paris, France
– sequence: 14
  givenname: Moreno
  surname: Galleni
  fullname: Galleni, Moreno
  organization: Laboratoire des Macromolécules Biologiques, Centre d'Ingénierie des Protéines-InBioS, Université de Liège, Institute of Chemistry B6 a, Sart-Tilman, 4000 Liège, Belgium
– sequence: 15
  givenname: Jean-Denis
  orcidid: 0000-0001-9483-4476
  surname: Docquier
  fullname: Docquier, Jean-Denis
  organization: Dipartimento di Biotecnologie Mediche, Università di Siena, I-53100 Siena, Italy
– sequence: 16
  givenname: Jean-François
  surname: Hernandez
  fullname: Hernandez, Jean-François
  organization: Institut des Biomolécules Max Mousseron, UMR5247 CNRS, Université de Montpellier, ENSCM, Faculté de Pharmacie, 34093 Montpellier, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32717907$$D View this record in MEDLINE/PubMed
https://hal.science/hal-02997710$$DView record in HAL
BookMark eNpdkt1qFDEUxwep2Fp757UMeNPCRjP5mMx4ISxF7cL6ASp4F5LMmd1sM8mamV1YX8W38EF8JrMflm1DIIeT__mdP8l5mp344CHLnhf4FaU1fq1t6AqMqwLX7FF2RkhRISLoj5Oj-DS76PsFTqtKm9An2SklohA1FmfZb4Yu8085GrvbjUO58k2KTQpVZ324QsWIjBgaolW_ggNE0TC3yUI-9sqFWZ-rPv8Ig3IuoL9_0FSZQXWqh3zi51bbIcT-TT7plimfhzZnaGr9LcQ8-PxLGMCbza7l1yWYIa66reZQmbo8yx63yvVwcTjPs-_v3327vkHTzx8m1-MpMpyXAwIgStEGWNXighANNa44VqA4A0obppkA3NCW8ZKXpKalVqoVXHOBC8GEoefZZM9tglrIZbSdihsZlJW7RIgzqeJgjQOZsBog8Stes0bpqtR1C3Vbgmk1UW1ivd2zlivdQWPAD1G5e9D7N97O5SyspWAlr6oyAege4CzMIDXXVq7JrnAXr1xyY6QGSUhZScJqUfNUdbWvmj9odjOeym0Ok7oWosDrImkvDxZj-LmCfpCd7Q04pzyEVZ-QpMJlSegW-_KBdBFWMX39TiV4RZOJpBrtVSaGvo_Q3jkosNyOqTwe0yR_cfxEd-L_Q0n_AdNU45k
CitedBy_id crossref_primary_10_1002_cmdc_202100699
crossref_primary_10_1016_j_ejmech_2022_114677
crossref_primary_10_3390_biom11070986
crossref_primary_10_3390_molecules27123832
crossref_primary_10_3390_ph14070612
crossref_primary_10_1016_j_ejmech_2021_113873
crossref_primary_10_1016_j_bmc_2022_116964
crossref_primary_10_1021_acs_jmedchem_2c01257
crossref_primary_10_3390_M1380
crossref_primary_10_1080_13543776_2023_2262763
crossref_primary_10_3390_antibiotics12020306
crossref_primary_10_1016_j_micres_2022_127079
crossref_primary_10_1016_j_bioorg_2021_105024
crossref_primary_10_1016_j_bioorg_2021_105138
Cites_doi 10.1128/AAC.01963-19
10.1074/jbc.M104742200
10.1016/j.bmcl.2012.06.074
10.1097/MRM.0b013e3283587727
10.1128/AAC.00074-18
10.1002/jcc.21256
10.1128/AAC.01336-09
10.1002/cmdc.201700186
10.1021/acs.jpcb.7b01053
10.1016/S1473-3099(17)30753-3
10.1021/acs.jmedchem.9b01279
10.3109/14756366.2016.1172575
10.1016/j.bmcl.2011.10.116
10.1016/j.jmb.2007.10.036
10.1128/AAC.43.4.902
10.1021/jo400236f
10.1021/acsmedchemlett.7b00428
10.3390/ph13030052
10.1089/mdr.1996.2.253
10.1016/j.bmcl.2011.04.027
10.1128/AAC.01486-09
10.4155/fmc-2017-0007
10.1021/acs.jmedchem.9b01518
10.2147/IDR.S173867
10.1101/cshperspect.a025239
10.1093/jac/dkg067
10.1007/7355_2017_24
10.1016/j.drudis.2008.07.005
10.1128/AAC.01768-15
10.3389/fmicb.2018.02928
10.1042/BST0380888
10.1021/acs.jmedchem.7b00407
10.1016/j.drup.2017.11.002
10.1016/j.bmc.2005.11.046
10.1021/acsinfecdis.8b00247
10.1016/j.tips.2018.03.007
10.1016/j.pep.2005.01.016
10.1074/jbc.M414052200
10.1093/femsre/fuz014
10.1021/acs.jmedchem.9b01976
10.2174/1389450116666151001105622
10.1021/acs.jmedchem.5b01289
10.1254/jjp.63.187
10.1021/acs.jmedchem.9b00911
10.1039/b802311e
10.1002/cmdc.201402249
10.1038/s41579-019-0159-8
10.1002/jcc.20084
10.1038/nature13445
10.1016/S1074-5521(03)00070-X
10.1021/acsinfecdis.8b00246
10.1128/AAC.46.6.1823-1830.2002
10.1021/jm100213c
10.1093/jac/dkg126
ContentType Journal Article
Web Resource
Copyright 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Attribution
2020 by the authors. 2020
Copyright_xml – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Attribution
– notice: 2020 by the authors. 2020
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7T5
7TM
7TO
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
1XC
VOOES
Q33
5PM
DOA
DOI 10.3390/biom10081094
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Complete (ProQuest Database)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
ProQuest Publicly Available Content database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
Université de Liège - Open Repository and Bibliography (ORBI)
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
CrossRef
MEDLINE



MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2218-273X
ExternalDocumentID oai_doaj_org_article_0aebee0858594dab86b9fe9f6ecfb2af
oai_orbi_ulg_ac_be_2268_249795
oai_HAL_hal_02997710v1
10_3390_biom10081094
32717907
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Agence Nationale de la Recherche
  grantid: ANR-14-CE16-0028-01
GroupedDBID 3V.
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AADQD
AAFWJ
ABDBF
ABUWG
ADBBV
AFKRA
AFPKN
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CUY
CVF
EBD
ECM
EIF
ESX
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
IAO
KQ8
LK8
M1P
M48
M7P
MODMG
M~E
NPM
OK1
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RPM
UKHRP
AAYXX
CITATION
7T5
7TM
7TO
7XB
8FK
AZQEC
DWQXO
GNUQQ
H94
K9.
PQEST
PQUKI
PRINS
7X8
1XC
VOOES
ADRAZ
IPNFZ
ITC
Q33
5PM
ID FETCH-LOGICAL-c556t-ee2aa3de48f0122be90850aea54e33d4b47e0d3f456562936baaf75b5701747c3
IEDL.DBID RPM
ISSN 2218-273X
IngestDate Tue Oct 22 15:12:29 EDT 2024
Tue Sep 17 21:27:12 EDT 2024
Fri Nov 08 14:53:27 EST 2024
Tue Oct 15 15:52:48 EDT 2024
Sat Oct 26 05:58:23 EDT 2024
Thu Oct 10 20:32:52 EDT 2024
Thu Sep 26 21:29:24 EDT 2024
Sat Nov 02 12:27:03 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords β-lactam antibiotics
1,2,4-triazole-3-thione
enzyme inhibitors
metallo-β-lactamase
bacterial resistance
4-triazole-3-thione
1
Metallo-β-lactamase
2
Enzyme inhibitors
Bacterial resistance
Language English
License Attribution: http://creativecommons.org/licenses/by
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c556t-ee2aa3de48f0122be90850aea54e33d4b47e0d3f456562936baaf75b5701747c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC7465886
Grant ANR-14-CE16-0028-01
scopus-id:2-s2.0-85088573230
ORCID 0000-0003-3001-8159
0000-0003-0668-4063
0000-0001-8660-0944
0000-0002-2347-2495
0000-0001-9483-4476
0000-0003-0146-1848
0000-0002-3818-105X
0000-0003-1609-2272
0000-0003-3560-9361
0000-0001-7174-2907
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465886/
PMID 32717907
PQID 2427583226
PQPubID 2032425
ParticipantIDs doaj_primary_oai_doaj_org_article_0aebee0858594dab86b9fe9f6ecfb2af
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7465886
liege_orbi_v2_oai_orbi_ulg_ac_be_2268_249795
hal_primary_oai_HAL_hal_02997710v1
proquest_miscellaneous_2428066235
proquest_journals_2427583226
crossref_primary_10_3390_biom10081094
pubmed_primary_32717907
PublicationCentury 2000
PublicationDate 20200723
PublicationDateYYYYMMDD 2020-07-23
PublicationDate_xml – month: 7
  year: 2020
  text: 20200723
  day: 23
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Biomolecules (Basel, Switzerland)
PublicationTitleAlternate Biomolecules
PublicationYear 2020
Publisher MDPI AG
MDPI
Multidisciplinary Digital Publishing Institute (MDPI)
Publisher_xml – name: MDPI AG
– name: MDPI
– name: Multidisciplinary Digital Publishing Institute (MDPI)
References Ventola (ref_8) 2015; 40
Freire (ref_52) 2008; 13
Bebrone (ref_43) 2005; 280
Morris (ref_47) 2009; 16
Feng (ref_59) 2012; 22
McGeary (ref_17) 2017; 9
Brindisi (ref_49) 2016; 31
Fernandes (ref_1) 2013; 24
Zhang (ref_61) 2014; 9
Sanner (ref_48) 1999; 17
Docquier (ref_40) 2002; 46
Fischer (ref_3) 2017; Volume 25
Makena (ref_16) 2016; 60
Everett (ref_28) 2018; 62
Peterson (ref_2) 2018; 9
Christopeit (ref_56) 2015; 58
Yang (ref_46) 2003; 51
ref_60
Bonomo (ref_11) 2017; 7
Christopeit (ref_62) 2016; 72
Olsen (ref_33) 2006; 14
Tacconelli (ref_9) 2018; 18
King (ref_22) 2014; 510
ref_24
Docquier (ref_41) 2003; 51
Vella (ref_55) 2011; 21
Ju (ref_13) 2018; 39
Liu (ref_26) 2020; 63
Krajnc (ref_27) 2019; 62
Laws (ref_5) 2019; 43
Galleni (ref_42) 1996; 2
Linciano (ref_15) 2019; 5
Spyrakis (ref_57) 2018; 9
Mojica (ref_14) 2016; 17
Lassaux (ref_19) 2010; 53
Lassaux (ref_50) 2011; 55
Nauton (ref_34) 2008; 375
Borgianni (ref_45) 2010; 54
Laraki (ref_39) 1999; 43
Leiris (ref_29) 2019; 5
Moali (ref_51) 2003; 10
ref_30
Ladbury (ref_53) 2010; 38
Bush (ref_12) 2019; 17
Sevaille (ref_35) 2017; 12
Worthington (ref_10) 2013; 78
ref_37
Zaman (ref_7) 2017; 9
Hamrick (ref_25) 2020; 64
Pettersen (ref_54) 2004; 25
Matsuura (ref_23) 1993; 63
Docquier (ref_31) 2018; 36
Aslam (ref_4) 2018; 11
Garau (ref_18) 2008; 6
Toney (ref_20) 2001; 276
ref_44
Studier (ref_38) 2005; 41
Faridoon (ref_58) 2012; 22
Chen (ref_21) 2017; 60
Pernas (ref_32) 2020; 63
Kwapien (ref_36) 2017; 121
ref_6
References_xml – volume: 64
  start-page: 1
  year: 2020
  ident: ref_25
  article-title: VNRX-5133 (Taniborbactam), a broad-spectrum inhibitor of serine- and metallo-β-lactamase, restores activity of cefepime in Enterobacterales and Pseudomonas aeruginosa
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01963-19
  contributor:
    fullname: Hamrick
– volume: 276
  start-page: 31913
  year: 2001
  ident: ref_20
  article-title: Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-β-lactamase
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M104742200
  contributor:
    fullname: Toney
– volume: 22
  start-page: 5185
  year: 2012
  ident: ref_59
  article-title: N-Heterocyclic dicarboxylic acids: Broad-spectrum inhibitors of metallo-β-lactamases with co-antibacterial effect against antibiotic-resistant bacteria
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2012.06.074
  contributor:
    fullname: Feng
– volume: 24
  start-page: 7
  year: 2013
  ident: ref_1
  article-title: β-Lactams: Chemical structure, mode of action and mechanisms of resistance
  publication-title: Rev. Med. Microbiol.
  doi: 10.1097/MRM.0b013e3283587727
  contributor:
    fullname: Fernandes
– volume: 62
  start-page: 7
  year: 2018
  ident: ref_28
  article-title: Discovery of a novel metallo-β-lactamase inhibitor that potentiates meropenem activity against carbapenem-resistant Enterobacteriaceae
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.00074-18
  contributor:
    fullname: Everett
– volume: 16
  start-page: 2785
  year: 2009
  ident: ref_47
  article-title: AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
  publication-title: J. Comput. Chem.
  doi: 10.1002/jcc.21256
  contributor:
    fullname: Morris
– volume: 54
  start-page: 3197
  year: 2010
  ident: ref_45
  article-title: Mutational analysis of VIM-2 reveals an essential determinant for metallo-β-lactamase stability and folding
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01336-09
  contributor:
    fullname: Borgianni
– volume: 12
  start-page: 972
  year: 2017
  ident: ref_35
  article-title: 1,2,4-Triazole-3-thione compounds as inhibitors of dizinc metallo-β-lactamases
  publication-title: Chem. Med. Chem.
  doi: 10.1002/cmdc.201700186
  contributor:
    fullname: Sevaille
– volume: 121
  start-page: 6295
  year: 2017
  ident: ref_36
  article-title: Calibration of 1,2,4-triazole-3-thione, an original Zn-binding group of metallo-β-lactamase inhibitors. Validation of a polarizable MM/MD potential by quantum chemistry
  publication-title: J. Phys. Chem. B
  doi: 10.1021/acs.jpcb.7b01053
  contributor:
    fullname: Kwapien
– volume: 18
  start-page: 318
  year: 2018
  ident: ref_9
  article-title: Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(17)30753-3
  contributor:
    fullname: Tacconelli
– volume: 63
  start-page: 1859
  year: 2020
  ident: ref_32
  article-title: β-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.9b01279
  contributor:
    fullname: Pernas
– volume: 31
  start-page: 98
  year: 2016
  ident: ref_49
  article-title: Targeting clinically-relevant metallo-β-lactamases: From high-throughput docking to broad-spectrum inhibitors
  publication-title: J. Enzyme Inhib. Med. Chem.
  doi: 10.3109/14756366.2016.1172575
  contributor:
    fullname: Brindisi
– volume: 22
  start-page: 383
  year: 2012
  ident: ref_58
  article-title: 3-Mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-β-lactamase inhibitors
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2011.10.116
  contributor:
    fullname: Faridoon
– volume: 375
  start-page: 257
  year: 2008
  ident: ref_34
  article-title: Structural insights into the design of inhibitors for the L1 metallo-β-lactamase from Stenotrophomonas maltophilia
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2007.10.036
  contributor:
    fullname: Nauton
– volume: 43
  start-page: 902
  year: 1999
  ident: ref_39
  article-title: Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.43.4.902
  contributor:
    fullname: Laraki
– volume: 78
  start-page: 4207
  year: 2013
  ident: ref_10
  article-title: Overcoming resistance to β-lactam antibiotics
  publication-title: J. Org. Chem.
  doi: 10.1021/jo400236f
  contributor:
    fullname: Worthington
– volume: 9
  start-page: 45
  year: 2018
  ident: ref_57
  article-title: Structure-based virtual screening for the discovery of novel inhibitors of New Delhi Metallo-β-lactamase-1
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/acsmedchemlett.7b00428
  contributor:
    fullname: Spyrakis
– ident: ref_60
  doi: 10.3390/ph13030052
– volume: 2
  start-page: 253
  year: 1996
  ident: ref_42
  article-title: Overproduction and purification of the Aeromonas hydrophila CphA metallo-β-lactamse expressed in Escherichia coli
  publication-title: Microb. Drug Resist.
  doi: 10.1089/mdr.1996.2.253
  contributor:
    fullname: Galleni
– volume: 21
  start-page: 3282
  year: 2011
  ident: ref_55
  article-title: The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2011.04.027
  contributor:
    fullname: Vella
– volume: 55
  start-page: 1248
  year: 2011
  ident: ref_50
  article-title: Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01486-09
  contributor:
    fullname: Lassaux
– volume: 9
  start-page: 1
  year: 2017
  ident: ref_7
  article-title: A review on antibiotic resistance: Alarm bells are ringing
  publication-title: Cureus
  contributor:
    fullname: Zaman
– volume: 9
  start-page: 673
  year: 2017
  ident: ref_17
  article-title: Progress toward inhibitors of metallo-β-lactamases
  publication-title: Future Med. Chem.
  doi: 10.4155/fmc-2017-0007
  contributor:
    fullname: McGeary
– volume: 63
  start-page: 2789
  year: 2020
  ident: ref_26
  article-title: Discovery of Taniborbactam (VNRX-5133): A broad-spectrum serine- and metallo-β-lactamase inhibitor for carbapenem-resistant bacterial infections
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.9b01518
  contributor:
    fullname: Liu
– volume: 11
  start-page: 1645
  year: 2018
  ident: ref_4
  article-title: Antibiotic resistance: A rundown of a global crisis
  publication-title: Infect. Drug Resist.
  doi: 10.2147/IDR.S173867
  contributor:
    fullname: Aslam
– volume: 7
  start-page: 1
  year: 2017
  ident: ref_11
  article-title: β-Lactamases: A focus on current challenges
  publication-title: Cold Spring Harb. Perspect. Med.
  doi: 10.1101/cshperspect.a025239
  contributor:
    fullname: Bonomo
– volume: 17
  start-page: 57
  year: 1999
  ident: ref_48
  article-title: Python: A programming language for software integration and development
  publication-title: J. Mol. Graph. Mod.
  contributor:
    fullname: Sanner
– volume: 51
  start-page: 257
  year: 2003
  ident: ref_41
  article-title: On functional and structural heterogeneity of VIM-type metallo-β-lactamases
  publication-title: J. Antimicrob. Chemother.
  doi: 10.1093/jac/dkg067
  contributor:
    fullname: Docquier
– volume: Volume 25
  start-page: 31
  year: 2017
  ident: ref_3
  article-title: The antibiotic future
  publication-title: Antibacterials
  doi: 10.1007/7355_2017_24
  contributor:
    fullname: Fischer
– volume: 40
  start-page: 277
  year: 2015
  ident: ref_8
  article-title: The antibiotic resistance crisis. Part 1: Causes and Threats
  publication-title: Pharm. Ther.
  contributor:
    fullname: Ventola
– ident: ref_24
– volume: 13
  start-page: 869
  year: 2008
  ident: ref_52
  article-title: Do enthalpy and entropy distinguish first class from best in class?
  publication-title: Drug Discov. Today
  doi: 10.1016/j.drudis.2008.07.005
  contributor:
    fullname: Freire
– volume: 60
  start-page: 1377
  year: 2016
  ident: ref_16
  article-title: Comparison of Verona Integron-borne Metallo-β-lactamase (VIM) variants reveals differences in stability and inhibition profiles
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01768-15
  contributor:
    fullname: Makena
– volume: 9
  start-page: 2928
  year: 2018
  ident: ref_2
  article-title: Antibiotic resistance mechanisms in bacteria: Relationships between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2018.02928
  contributor:
    fullname: Peterson
– volume: 38
  start-page: 888
  year: 2010
  ident: ref_53
  article-title: Calorimetry as a tool for understanding biomolecular interactions and an aid to drug design
  publication-title: Biochem. Soc. Trans.
  doi: 10.1042/BST0380888
  contributor:
    fullname: Ladbury
– volume: 60
  start-page: 7267
  year: 2017
  ident: ref_21
  article-title: Dipicolinic acid derivatives as inhibitors of New Delhi Metallo-β-lactamase-1
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.7b00407
  contributor:
    fullname: Chen
– ident: ref_37
– volume: 36
  start-page: 13
  year: 2018
  ident: ref_31
  article-title: An update on β-lactamase inhibitor discovery and development
  publication-title: Drug Resist. Update
  doi: 10.1016/j.drup.2017.11.002
  contributor:
    fullname: Docquier
– volume: 14
  start-page: 2627
  year: 2006
  ident: ref_33
  article-title: New leads of metallo-β-lactamase inhibitors from structure-based pharmacophore design
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2005.11.046
  contributor:
    fullname: Olsen
– ident: ref_44
– volume: 5
  start-page: 9
  year: 2019
  ident: ref_15
  article-title: Ten years with New Delhi Metallo-β-Lactamase-1 (NDM-1): From structural insights to inhibitor design
  publication-title: ACS Infect. Dis.
  doi: 10.1021/acsinfecdis.8b00247
  contributor:
    fullname: Linciano
– volume: 39
  start-page: 635
  year: 2018
  ident: ref_13
  article-title: The continuing challenge of metallo-β-lactamase inhibition: Mechanism matters
  publication-title: Trends Pharmacol. Sci.
  doi: 10.1016/j.tips.2018.03.007
  contributor:
    fullname: Ju
– volume: 41
  start-page: 207
  year: 2005
  ident: ref_38
  article-title: Protein production by auto-induction in high density shaking cultures
  publication-title: Protein Expr. Purif.
  doi: 10.1016/j.pep.2005.01.016
  contributor:
    fullname: Studier
– volume: 280
  start-page: 28195
  year: 2005
  ident: ref_43
  article-title: Dramatic broadening of the substrate profile of the Aeromonas hydrophila CphA metallo-β-lactamase by site-directed mutagenesis
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M414052200
  contributor:
    fullname: Bebrone
– volume: 43
  start-page: 490
  year: 2019
  ident: ref_5
  article-title: Antibiotic resistance breakers: Current approaches and future directions
  publication-title: FEMS Microbiol. Rev.
  doi: 10.1093/femsre/fuz014
  contributor:
    fullname: Laws
– ident: ref_30
  doi: 10.1021/acs.jmedchem.9b01976
– volume: 17
  start-page: 1029
  year: 2016
  ident: ref_14
  article-title: B1-Metallo-β-lactamases: Where do we stand?
  publication-title: Curr. Drug Targets
  doi: 10.2174/1389450116666151001105622
  contributor:
    fullname: Mojica
– ident: ref_6
– volume: 58
  start-page: 8671
  year: 2015
  ident: ref_56
  article-title: Discovery of novel inhibitor scaffolds against the metallo-β-lactamase VIM-2 by surface plasmon resonance (SPR) based fragment screening
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.5b01289
  contributor:
    fullname: Christopeit
– volume: 63
  start-page: 187
  year: 1993
  ident: ref_23
  article-title: Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors
  publication-title: JPN J. Pharmacol.
  doi: 10.1254/jjp.63.187
  contributor:
    fullname: Matsuura
– volume: 62
  start-page: 8544
  year: 2019
  ident: ref_27
  article-title: Bicyclic boronate VNRX-5133 inhibits metallo- and serine β-lactamases
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.9b00911
  contributor:
    fullname: Krajnc
– volume: 6
  start-page: 2282
  year: 2008
  ident: ref_18
  article-title: Structural basis for the broad-spectrum inhibition of metallo-β-lactamases by thiols
  publication-title: Org. Biomol. Chem.
  doi: 10.1039/b802311e
  contributor:
    fullname: Garau
– volume: 9
  start-page: 2445
  year: 2014
  ident: ref_61
  article-title: Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi Metallo-β-lactamase-1 (NDM-1)
  publication-title: Chem. Med. Chem.
  doi: 10.1002/cmdc.201402249
  contributor:
    fullname: Zhang
– volume: 17
  start-page: 295
  year: 2019
  ident: ref_12
  article-title: Interplay between β-lactamases and new β-lactamase inhibitors
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/s41579-019-0159-8
  contributor:
    fullname: Bush
– volume: 25
  start-page: 1605
  year: 2004
  ident: ref_54
  article-title: UCSF Chimera-A visualization system for exploratory research and analysis
  publication-title: J. Comput. Chem.
  doi: 10.1002/jcc.20084
  contributor:
    fullname: Pettersen
– volume: 510
  start-page: 503
  year: 2014
  ident: ref_22
  article-title: Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
  publication-title: Nature
  doi: 10.1038/nature13445
  contributor:
    fullname: King
– volume: 10
  start-page: 319
  year: 2003
  ident: ref_51
  article-title: Analysis of the importance of the metallo-β-lactamase active site loop in substrate binding and catalysis
  publication-title: Chem. Biol.
  doi: 10.1016/S1074-5521(03)00070-X
  contributor:
    fullname: Moali
– volume: 5
  start-page: 131
  year: 2019
  ident: ref_29
  article-title: SAR studies leading to the identification of a novel series of metallo-β-lactamase inhibitors for the treatment of carbapenem-resistant Enterobacteriaceae infections that display efficacy in an animal infection model
  publication-title: ACS Infect. Dis.
  doi: 10.1021/acsinfecdis.8b00246
  contributor:
    fullname: Leiris
– volume: 46
  start-page: 1823
  year: 2002
  ident: ref_40
  article-title: CAU-1, a subclass B3 metallo-β-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosome
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.46.6.1823-1830.2002
  contributor:
    fullname: Docquier
– volume: 53
  start-page: 4862
  year: 2010
  ident: ref_19
  article-title: Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-β-lactamases
  publication-title: J. Med. Chem.
  doi: 10.1021/jm100213c
  contributor:
    fullname: Lassaux
– volume: 51
  start-page: 545
  year: 2003
  ident: ref_46
  article-title: Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli
  publication-title: J. Antimicrob. Chemother.
  doi: 10.1093/jac/dkg126
  contributor:
    fullname: Yang
– volume: 72
  start-page: 813
  year: 2016
  ident: ref_62
  article-title: The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor
  publication-title: Acta Cryst.
  contributor:
    fullname: Christopeit
RestrictionsOnAccess restricted access
SSID ssj0000800823
Score 2.3074496
Snippet To fight the increasingly worrying bacterial resistance to antibiotics, the discovery and development of new therapeutics is urgently needed. Here, we report...
SourceID doaj
pubmedcentral
liege
hal
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1094
SubjectTerms 1,2,4-triazole-3-thione
Anti-Bacterial Agents
Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - pharmacology
Antibiotics
Bacteria
Bacterial Infections
Bacterial Infections - microbiology
Bacterial Infections - prevention & control
bacterial resistance
Beta-Lactamase Inhibitors
beta-Lactamase Inhibitors - chemistry
beta-Lactamase Inhibitors - pharmacology
Beta-Lactamases
beta-Lactamases - metabolism
Beta-Lactams
beta-Lactams - chemistry
beta-Lactams - pharmacology
Biocatalysis
Biocatalysis - drug effects
Biochemistry, biophysics & molecular biology
Biochimie, biophysique & biologie moléculaire
Calorimetry
Carbapenems
Carbapenems - chemistry
Carbapenems - pharmacology
Chemical Sciences
Drug development
Drug resistance
Drug Resistance, Bacterial
Drug Resistance, Bacterial - drug effects
enzyme inhibitors
Enzymes
Gram-Negative Bacteria
Gram-Negative Bacteria - drug effects
Gram-Negative Bacteria - metabolism
Humans
Hydrazine
Infections
Life sciences
Medicinal Chemistry
Metallo-β-lactamase
Microbial Sensitivity Tests
Microbiologie
Microbiology
Molecular Structure
Pathogens
Physicochemical properties
Sciences du vivant
Thiones
Thiones - chemistry
Titration
Triazoles
Triazoles - chemistry
Zinc
β-Lactam antibiotics
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQuXBBlPITWpBBgEBaq1nbiWNuC6LaorbiQKXeLDtx2IVsgrrZSsub8Bo8CM_EjJOuNgiJC9pLFM_aTmbs-fHkG0Ke6yRPC61LlvPCMpmMc-aKccZS7jDor0GpYLzj9CydnssPF8nFVqkvzAnr4IG7F3cYWxjGx3h8pWVhXZY6XXpdpj4vHbdl2H1jveVMfentoIyLLtNdgF9_iF-zI5AN0MqBDgpQ_aBZZpgIebPCo-q_WZt_Jk1uaaGjO-R2bz7SSTftXXLD13fJ3qQG13mxpi9pSOgMkfI98kOyV2dsUn1dV4zauqBsksOlXczr5jUbj_hIMiza8b2pPBOsnSFoEUWUkubzktolPfUtHsuzXz_Zic1buwCNR4_r2dzNsUbPG3ocPrGkTUklQ6fWX9Kmph8btMPXYUgsb99erhZI0_8TRrlHzo_ef3o3ZX0lBpYnSdoy77m1ovAyK_EoznmNSHfW20R6IQrppPJxIcpgHoIBkTprS5W4RMGClyoX98lODc_wkNAUIftU7rSX8HMYeAIfFHaCxI99lqUReXHNG_OtA9ww4KggD802DyPyFhm3oUGY7HADhMf0wmP-JTwReQZsH_QxnZwYvBeDnlZgfl2NIzIKUgE9u7m54oEsXK8qGCo3zhswYjMDnqzSSUQOroXH9PvBEpo4OGawecLzPd00w0rG4xlb-2YVaDLE4xfQxYNO1jYzE1whlJqKiBpI4WDqw5Z6Pgto4UqCkZmlj_7H-9ontzjGG2LFuDggOyBA_jEYZa17EtbfbySWNtY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Complete (ProQuest Database)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dbtMwFLZgu-EGAeMnMJBBgECqtSR27IQbVBBTh7aJCyb1zrIdZ63WJqNNJ5U34TV4EJ6Jc9y0rAih3ESxYzs6xz6_-Q4hL4vMybIoKubS0jCRJY7ZMsmZTC06_QsQKujvODmVgzPxeZgNO4fbvEurXJ-J4aAuG4c-8gMQJaDaAvvJ95ffGFaNwuhqV0LjJtlN0lhiSpcaqo2PBbWhPOWrfHcO1v0B_tOOcDZJXIgtSRQA-0G-jDAdcneCAet_6Zx_p05ek0WHd8jtTomk_RXV75Ibvr5H9vo1GNDTJX1NQ1pn8JfvkR-CvTll_cnFcsKoqUvK-g5uzXRcN29Z0kt7gmHpju_NxDPO2hFCF1HEKmnO59TM6YlvMTjPfv1kx8a1Zgpyjx7Vo7EdY6Wed_Qo_GhJm4oKhqatn9Gmpl8a1MaXYUosct_OFlPs070Js9wnZ4efvn4csK4eA3NZJlvmfWoML73IKwzIWV8g3p3xJhOe81JYoXxc8iooiaBGSGtMpTKbKdj2Qjn-gOzU8A2PCJUI3KecLbyAy6L7CSxROA8yn_g8lxF5taaNvlzBbmgwV5CG-joNI_IBCbfpg2DZ4UEzO9fd3tOwROt9jBHQQpTG5tIWlS8q6V1lU1NF5AWQfWuMQf9Y47MYpLUCJewqiUgvcAWMbMf6Kg3dwv1iAlM5bb0G5sw12LOqyCKyv2Ye3Z0Kc_2HhyPyfNMM-xmDNKb2zSL0yRGVn8MQD1e8tlkZTxUCqqmIqC0u3Fr6dks9HgXMcCVA1czl4_8v6wm5laI_IVYs5ftkB1jDPwWlq7XPws76DSqLK9g
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access(OpenAccess)
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3rbtMwFLbGJqH9QcC4BAYyCBBIMzSOEydICBXE1KFtQoJK-2fZyclaSBPoZaK8Cm_Bg_BMnOOm1QpD_WPFju3Uxz7f58tnxh5lcZ4UWVaKXBZWqDjMhSvCVCTS0aR_hk6F5juOjpNeX70_iU822PK20fYPnFxI7eg-qf64ev792_w1dvhXxDiRsr-gg-qkURMiVbnEtqRCjk6b-Fqg_7nFRamMFjvf_3lpm12OpCatKr3mnryKPzqdAe2R3KpoFfsiIPr3fspzDmr_KrvSIkveXZjCNbYB9XW2062RVY_m_An3ez39JPoO-6nEU37MRbf6Mq8Et3WB4RyDdjSsm2ci3JN7StCNHj-aCkQkpgNSNOIkYdKcTrid8COY0pq9-P1LHNp8akfoDvlBPRi6IV3g85If-POXvCm5EsR4Ycybmn9oCKTPfZEf6ZTneDaiNO2bWMoN1t9_9-ltT7TXNIg8jpOpAJDWRgWotKR1OgcZyeBZsLGCKCqUUxo6RVR67IjoInHWljp2scbRQOk8usk2a_yG24wnpOenc5eBwp-jWSkkqDhMxBBCmiYBe7xsHfN1ocZhkMVQg5rzDRqwN9R0qzSkoe0fNONT03ZJg1V0AB1aGM1UYV2auKyErEwgL520ZcAeYsOv5dHrHhp61kEnrhGbnYUB2_N2gTm7oTmTPpkPzyosKjcODCLc1CDN1VkcsN2l-ZilrWOURNaGIyt-34NVNHZzWruxNTQznyYlsf4Is7i1sLZVzZa2GzC9ZodrVV-PqYcDLyWuFSLQNLnz3zzvsm1JMwwdLWS0yzbRKuAewrCpu-972B-nnC6S
  priority: 102
  providerName: Scholars Portal
Title 4-( N -Alkyl- and -Acyl-amino)-1,2,4-triazole-3-thione Analogs as Metallo-β-Lactamase Inhibitors: Impact of 4-Linker on Potency and Spectrum of Inhibition
URI https://www.ncbi.nlm.nih.gov/pubmed/32717907
https://www.proquest.com/docview/2427583226
https://search.proquest.com/docview/2428066235
https://hal.science/hal-02997710
http://orbi.ulg.ac.be/handle/2268/249795
https://pubmed.ncbi.nlm.nih.gov/PMC7465886
https://doaj.org/article/0aebee0858594dab86b9fe9f6ecfb2af
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZ2kdBeEDBggVEZBAikeW0SJ05466ZNHVqrCjGpb5HtOGsgl6mXSeWf8Df4IfwmznHTqkU8oUhRFDu2o3OOz8XHnwl5Gwc6TOM4Y9pLJeOBq5lK3YiFnsKgfwxKBeMd_UHYu-GfR8FohwSrvTA2aV-r_LQqytMqH9vcyrtSt1d5Yu1h_1xw0JtR2N4lu8CgGy76t8YEijx_meTug0vfxo3siGHjgitzQB74nkBYKrGliSxgP-iXMaZD7he4YP0vm_Pv1MkNXXT5iDxsjEjaXQ72Mdkx1RNy2K3AgS4X9D21aZ02Xn5IfnL2YcC6xfdFwaisUsq6Gh5lmVf1R-aeeCec4dEdP-rCMJ_NxghdRBGrpL6dUjmlfTPDxXn2-xe7lnomS9B79Koa5yrHk3o-0Su70ZLWGeUMXVszoXVFhzVa4wvbJR5yP5vMS6zTfAm9PCU3lxdfz3usOY-B6SAIZ8wYT0o_NTzKcEFOmRjx7qSRATe-n3LFhemkfmaNRDAjQiVlJgIVCBB7LrT_jOxV8A9HhIYI3Ce0ig2HS2H4CTxRmA8C4xogrUPerWiT3C1hNxJwV5CcySY5HXKGhFvXQbBs-6Ke3CYNyyQwRGVMB1dAY55KFYUqzkychUZnypOZQ94A2bfa6HWvE3zXAW0twAi7dx1yYrkCWlZ5cu_ZavZ5XkBXOlEmAVM2SsCfFXHgkOMV8yTNrDCFIg_cM5hC4f9er4tBnnGRRlamnts6EaLy-9DE8yWvrUe24lyHiC0u3Br6dgmIkMUMb0TmxX9_-ZIceBhq6Ajm-cdkD7jGvAJ7bKZaIIUj0SL7ZxeD4ZeWjWrAvc-jlpXMP0_LOTs
link.rule.ids 230,315,730,783,787,867,888,2109,2228,12068,21400,24330,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806,74073,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9MwELZge4AXBAxYYIBBgECqtSZ24pgXVBBTC23Fwyb1zbITZ61ok9Gmk8o_4W_wQ_hN3LlpWRFCfYkS13Z0Z993d853hLxQcZbkShUsi3LDRBxmzOZhypLIYtBfgVHBeMdgmHTPxKdRPGoCbovmWOVmT_QbdV5lGCM_BlMC0BbUL3l38Y1h1SjMrjYlNK6TfeThwgoGciS3MRZEQ2nE1-fdOXj3x_hNO9LZhG0ldiyRJ-wH-zLG45D7U0xY_wtz_n108ootOrlNbjUgknbWUr9DrrnyLjnolOBAz1b0FfXHOn28_ID8EOz1kHWmX1dTRk2ZU9bJ4NLMJmX1hoWtqCUYlu74Xk0d46weI3URRa6S6nxBzYIOXI3JefbrJ-ubrDYzsHu0V44ndoKVet7Snv_QklYFFQxdWzenVUm_VIjGV35ILHJfz5czbNP8E0a5R85OPp5-6LKmHgPL4jipmXORMTx3Ii0wIWedQr4740wsHOe5sEK6ds4LDxIBRiTWmELGNpaw7IXM-H2yV8I7HBKaIHGfzKxyAn4Ww0_gicJ-ELvQpWkSkJcb2eiLNe2GBncFZaivyjAg71Fw2zZIlu1vVPNz3aw9DVO0zrUxA6pEbmyaWFU4VSQuK2xkioA8B7Hv9NHt9DXea4O1lgDCLsOAtLxWQM92oi8j38xfL6cwVKat06CcqQZ_Vqo4IEcb5dHNrrDQf3Q4IM-2j2E9Y5LGlK5a-jYpsvJz6OLBWte2M-ORREI1GRC5o4U7U999Uk7GnjNcCoCaafLw_9N6Sm50Twd93e8NPz8iNyOMLbQli_gR2QM1cY8BgNX2iV9lvwFQbS6_
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dbtMwFLZgkxA3CBg_gQEGAQKpVpvYiWNuUPmpWuiqXTBpd5adOGtFm4w2nVTehNfgQXgmznHTsiKEehMlru3oHJ__fIeQ5yrOklypgmVRbpiIw4zZPExZElkM-itQKhjvOBol_RPx6TQ-beqfFk1Z5UYmekGdVxnGyNugSsC0BfZL2kVTFnH8off2_BvDDlKYaW3aaVwl-xK8FOR5eSq38Ra0jNKIr2vfOXj6bfy-HaFtwo4SO1rJg_eDrhljaeT-FJPX_7I__y6jvKSXejfJjcagpN01B9wiV1x5mxx0S3CmZyv6kvoSTx87PyA_BHs1Yt3p19WUUVPmlHUzuDSzSVm9ZmEragmGbTy-V1PHOKvHCGNEEbekOltQs6BHrsZEPfv1kw1NVpsZ6EA6KMcTO8GuPW_owH90SauCCoZurpvTqqTHFVrmK78kNryv58sZjmn-CavcISe9j1_e91nTm4FlcZzUzLnIGJ47kRaYnLNOIfadcSYWjvNcWCFdJ-eFNxjBpEisMYWMbSxBBAiZ8btkr4R3uE9ogiB-MrPKCfhZDEWBVwqyIXahS9MkIC82tNHnawgODa4L0lBfpmFA3iHhtmMQONvfqOZnujmHGrZonetgNlSJ3Ng0sapwqkhcVtjIFAF5BmTfmaPfHWq81wHNLcEguwgD0vJcATPbib6I_DB_vZzCUpm2TgOjphp8W6nigBxumEc3EmKh__BzQJ5uH8PZxoSNKV219GNSROjnMMW9Na9td8YjieBqMiByhwt3tr77pJyMPX64FGB2psmD_2_rCbkGB0wPB6PPD8n1CMMMHckifkj2gEvcI7DFavvYH7LfowQy9w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=4-%28+N+-Alkyl-+and+-Acyl-amino%29-1%2C2%2C4-triazole-3-thione+Analogs+as+Metallo-%CE%B2-Lactamase+Inhibitors%3A+Impact+of+4-Linker+on+Potency+and+Spectrum+of+Inhibition&rft.jtitle=Biomolecules+%28Basel%2C+Switzerland%29&rft.au=Gavara%2C+Laurent&rft.au=Verdirosa%2C+Federica&rft.au=Legru%2C+Alice&rft.au=Mercuri%2C+Paola+Sandra&rft.date=2020-07-23&rft.eissn=2218-273X&rft.volume=10&rft.issue=8&rft_id=info:doi/10.3390%2Fbiom10081094&rft_id=info%3Apmid%2F32717907&rft.externalDocID=32717907
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2218-273X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2218-273X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2218-273X&client=summon